BioPharm News

Aug 14, 2018
By BioPharm International Editors
Drug product approval from FDA follows previous approvals from European and Japanese authorities.
Aug 14, 2018
By BioPharm International Editors
Pharmaceutical scientist association announces upcoming term’s board of directors.
Aug 13, 2018
By BioPharm International Editors
The new drug, Onpattro (patisiran), by Alnylam Pharmaceuticals, is in a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
Aug 10, 2018
By BioPharm International Editors
Only 54% of North Americans feel informed about the requirements of the general data protection regulation (GDPR), according to a report by GlobalData.
Aug 10, 2018
By BioPharm International Editors
The agency issued a warning letter to Canadian API manufacturer, Les Produits Chimiques B.G.R, citing cGMP violations at its API facility in Pointe-Claire, Quebec.
Aug 09, 2018
By BioPharm International Editors
The European Medicines Agency (EMA) will temporarily scale back activities as it copes with “significant staff loss” and prepares for the next phase in its continuity plan.
Aug 09, 2018
By BioPharm International Editors
The combined companies will provide research- and clinical-grade human immune cells, blood products, and related services.
Aug 09, 2018
By BioPharm International Editors
Ebola vaccinations by the World Health Organization began in North Kivu, Democratic Republic of the Congo, one week after the country’s latest outbreak.
Aug 09, 2018
By BioPharm International Editors
The Alliance for Regenerative Medicine’s (ARM) report highlights major trends and metrics from the 2018 second quarter in the regenerative medicines sector.
Aug 08, 2018
By BioPharm International Editors
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
native1_300x100
lorem ipsum